Due to Hurricane Zeta affecting our area, shipping will be delayed on Wednesday, October 28th. Our office will remain open, and we expect to resume normal operations on Thursday, October 29th. If you need immediate assistance, please contact us by email at email@example.com and we will respond as quickly as possible. Thank you for your continued support.
Bayer-backed study looks at how patients’ perceive digital products in care, clinical trials
ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the pharmaceutical company.
Published date: April 12th, 2018
By: Dave Muoio, mobihealthnews.com